Careers  |  Sign In  |  Register  |   Twitter

Latest in Reuters Health News

By Bill Berkrot (Reuters) – AbbVie Inc’s all-oral hepatitis C therapy cured 96% of difficult-to-treat patients in a late-stage clinical trial after 12 weeks, researchers said. The study of 394 patients with the most common genotype 1 version of the virus tested the AbbVie regimen in people who...
BRUSSELS (Reuters) – The artificial sweetener aspartame – widely used in low-calorie soft drinks – poses no health risks at currently approved consumption levels, the European Union’s food safety watchdog said on Tuesday. The finding by the European Food Safety Authority (EFSA) will...
By Ransdell Pierson (Reuters) – Merck & Co said on Tuesday it will advance its experimental Alzheimer’s drug into late-stage trials among patients with mild to moderate disease, after an independent monitoring board reviewed its safety and recommended the trial continue to recruit...